Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa.
Tanaka N, Izumi K, Nakai Y, Shima T, Kato Y, Mita K, Kamiyama M, Inoue S, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A.
Tanaka N, et al. Among authors: fukagai t.
Prostate. 2025 Jan;85(1):21-29. doi: 10.1002/pros.24796. Epub 2024 Sep 20.
Prostate. 2025.
PMID: 39301921
Clinical Trial.